Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2% (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cryomass Technologies Inc
CRYM
Cryomass Technologies Inc. designs, manufactures and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The Company through its CryoMass patented liquid nitrogen has built a...
Trichome Separation unit. The Trichome Separation system is optimized for the capture of fully intact cannabis and hemp trichomes, as well as terpenes. It can be used within minutes after plants have been cut and can also efficiently capture trichomes from fresh frozen or even dried plant parts, including trim. The CryoMass system, on the other hand, stabilizes and collects fully intact trichomes at harvest, leaving no opportunity for such wasteful loss.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:CRYM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(3)
•••
mezcal1
X
View Profile
View Bullboard History
Post by
mezcal1
on Jan 07, 2022 5:04pm
Quiet Board
This makes sense. Taxed on weight the shipping producers could save huge $$. Speed up supply chain as well.
(15)
•••
Systemtogo
X
View Profile
View Bullboard History
Comment by
Systemtogo
on Nov 18, 2021 1:58pm
RE:Anybody following CRYM?
This can potentially be massive. It almost seems too good to be true if their technology does indeed work. So it is very risky but massive reward in my opinion as the pot space is huge, where this
...more
Voyageur Pharmaceuticals Secures USD $1.9 Million Sales Contract for SmoothX 2%
posted May 28, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur's first international distribution agreement is over a three-year term with a company specializing in the sale of radiology products in Latin America. This initial agreement grants the distributor marketing and sales rights in two countries, for SmoothX 2%, a contrast medium for use in abdominal Computed Tomography (CT) diagnostic examinations. ...read more
(15)
•••
Systemtogo
X
View Profile
View Bullboard History
Post by
Systemtogo
on Nov 12, 2021 6:39pm
Anyone watch the Doug Casey video on Crym?
Really good story with this one. If they could pull it off, we could have a ten bagger here.
(3)
•••
lobojack
X
View Profile
View Bullboard History
Post by
lobojack
on Oct 13, 2021 11:55am
Anybody following CRYM?
0 debt, ~120 mil shares. Unique product - a money saver and huge productivity increases availabilble for cannibis growers. So apparently a great market. In production imminently, they say.
...more
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
April Sees Record Revenue for Cannabis Edibles Leader and Eyes Record Profitability in 2024
This Gambling Tech Stock Might be the Safest Bet you’ll make this Year